Search research articles
Contact Us
Filters
Showing results (91-100 of 104) with videos related to
Page
of 11
Sort By:
Urologic Oncology
|
February 21, 2024
Natural history of bone-only metastasis in renal cell carcinoma
Bixia Tang, Rong Duan, Zenan Fan, et al.
Frontiers in Oncology
|
June 7, 2021
Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy-<i>Ad hoc</i> Analyses of Pooled Data From Two Clinical Trials
Xue Bai, Jie Dai, Caili Li, et al.
Journal for Immunotherapy of Cancer
|
February 6, 2025
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights
Xuan Wang, Hui Tian, Zhihong Chi, et al.
Journal of Extracellular Vesicles
|
March 26, 2025
Dynamic Change of PD-L2 on Circulating Plasma Extracellular Vesicles as a Predictor of Treatment Response in Melanoma Patients Receiving Anti-PD-1 Therapy
Linzi Sun, Xiaoting Wei, Qian Zhao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2021
Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway
Lili Mao, Jie Dai, Yabin Cao, et al.
Frontiers in Oncology
|
July 18, 2022
Proliferation Marker Ki67 as a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal Melanoma
Lirui Tang, Xiaoting Wei, Caili Li, et al.
Frontiers in Oncology
|
September 10, 2021
Overall Survival of Patients With Unresectable or Metastatic BRAF V600-Mutant Acral/Cutaneous Melanoma Administered Dabrafenib Plus Trametinib: Long-Term Follow-Up of a Multicenter, Single-Arm Phase IIa Trial
Lili Mao, Ya Ding, Xue Bai, et al.
Signal Transduction and Targeted Therapy
|
November 21, 2024
Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial
Jiayong Liu, Xuan Wang, Zhongwu Li, et al.
Journal for Immunotherapy of Cancer
|
January 2, 2023
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy
Jie Dai, Xue Bai, Xuan Gao, et al.
JAAD International
|
March 19, 2024
Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: An international multicenter cohort study
Xue Bai, Aleigha R Lawless, Juliane A Czapla, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 104) with videos related to
Sort By:
Page
of 11
Urologic Oncology
|
February 21, 2024
Natural history of bone-only metastasis in renal cell carcinoma
Bixia Tang, Rong Duan, Zenan Fan, et al.
Frontiers in Oncology
|
June 7, 2021
Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy-<i>Ad hoc</i> Analyses of Pooled Data From Two Clinical Trials
Xue Bai, Jie Dai, Caili Li, et al.
Journal for Immunotherapy of Cancer
|
February 6, 2025
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights
Xuan Wang, Hui Tian, Zhihong Chi, et al.
Journal of Extracellular Vesicles
|
March 26, 2025
Dynamic Change of PD-L2 on Circulating Plasma Extracellular Vesicles as a Predictor of Treatment Response in Melanoma Patients Receiving Anti-PD-1 Therapy
Linzi Sun, Xiaoting Wei, Qian Zhao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2021
Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway
Lili Mao, Jie Dai, Yabin Cao, et al.
Frontiers in Oncology
|
July 18, 2022
Proliferation Marker Ki67 as a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal Melanoma
Lirui Tang, Xiaoting Wei, Caili Li, et al.
Frontiers in Oncology
|
September 10, 2021
Overall Survival of Patients With Unresectable or Metastatic BRAF V600-Mutant Acral/Cutaneous Melanoma Administered Dabrafenib Plus Trametinib: Long-Term Follow-Up of a Multicenter, Single-Arm Phase IIa Trial
Lili Mao, Ya Ding, Xue Bai, et al.
Signal Transduction and Targeted Therapy
|
November 21, 2024
Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial
Jiayong Liu, Xuan Wang, Zhongwu Li, et al.
Journal for Immunotherapy of Cancer
|
January 2, 2023
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy
Jie Dai, Xue Bai, Xuan Gao, et al.
JAAD International
|
March 19, 2024
Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: An international multicenter cohort study
Xue Bai, Aleigha R Lawless, Juliane A Czapla, et al.
Page
of 11